Showing results (181-190 of 288) with videos related to

Sort By:
Pageof 29
Glycoconjugate Journal|November 29, 2007
Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophilsKazuhisa Iwabuchi, Alessandro Prinetti, Sandro Sonnino, et al.
The American Journal of Cardiology|September 7, 2010
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stentsVictor Novack, Michael C Nguyen, Meredith Rooney, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trialDean J Kereiakes, Mark A Turco, Jeffrey Breall, et al.
Circulation. Cardiovascular Interventions|January 10, 2018
Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-AnalysisSammy Elmariah, Gheorghe Doros, Oscar R Benavente, et al.
American Heart Journal|December 15, 2010
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesionsLaura Mauri, Dean J Kereiakes, Sharon-Lise T Normand, et al.
Circulation|November 18, 2014
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placementKirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.
The New England Journal of Medicine|March 13, 2013
Nonemergency PCI at hospitals with or without on-site cardiac surgeryAlice K Jacobs, Sharon-Lise T Normand, Joseph M Massaro, et al.
American Heart Journal|March 20, 2012
Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trialOluseun O Alli, Paul S Teirstein, Lowell Satler, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 4, 2010
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II studyJean Fajadet, William Wijns, Gert-Jan Laarman, et al.
JACC. Cardiovascular Interventions|August 22, 2009
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registryVictor Novack, Donald Cutlip, Neal Kleiman, et al.
Pageof 29